News
Published studies, congresses and updates on REAC® Technology and ASMED® devices.
4 June 2026
REAC-NPO and REAC-NPPO neurobiological modulation treatments in the management of anxiety, depression and stress.
6 October 2025
Evidence on the technology in children with behavioural disorders, presented within the framework of the new European guide.
Reserved access
Access to the display of medical devices and information material is reserved for operators in the sector, in compliance with current legislation.
By continuing to browse, I declare that I am a healthcare professional.
EnterFor information on treatments you can contact the Rinaldi Fontani Institute in Florence.
Go to irf.itRegulation (EU) 2017/745 (MDR) and Legislative Decree No 137 of 5 August 2022